Tissue catabolism and donor-specific dexamethasone response in a human osteochondral model of post-traumatic osteoarthritis

[1]  A. Kengne,et al.  The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  S. Viswanathan,et al.  A tool for evaluating novel osteoarthritis therapies using multivariate analyses of human cartilage-synovium explant co-culture. , 2021, Osteoarthritis and cartilage.

[3]  Win Min Oo,et al.  The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date , 2021, Drug design, development and therapy.

[4]  A. Grodzinsky,et al.  Proteomic clustering reveals the kinetics of disease biomarkers in bovine and human models of post-traumatic osteoarthritis , 2021, Osteoarthritis and cartilage open.

[5]  Y. Henrotin,et al.  Osteomodulin impacts positively the bone remodeling process in osteoarthritis , 2021, Osteoarthritis and Cartilage.

[6]  Daming Gao,et al.  Osteomodulin positively regulates osteogenesis through interaction with BMP2 , 2021, Cell Death & Disease.

[7]  Chunli Song,et al.  Cellular alterations and crosstalk in the osteochondral joint in osteoarthritis and promising therapeutic strategies , 2021, Connective tissue research.

[8]  Anushya Muruganujan,et al.  PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API , 2020, Nucleic Acids Res..

[9]  Yongjae Lee,et al.  Positive Association of Serum Alkaline Phosphatase Level with Severe Knee Osteoarthritis: A Nationwide Population-Based Study , 2020, Diagnostics.

[10]  T. Vincent.  Of mice and men: converging on a common molecular understanding of osteoarthritis , 2020, The Lancet Rheumatology.

[11]  A. Grodzinsky,et al.  Proteomic analysis reveals dexamethasone rescues matrix breakdown but not anabolic dysregulation in a cartilage injury model , 2020, Osteoarthritis and cartilage open.

[12]  M. Karsdal,et al.  Osteoarthritis: Current Molecular Biomarkers and the Way Forward , 2020, Calcified Tissue International.

[13]  A. Grodzinsky,et al.  DEXAMETHASONE: CHONDROPROTECTIVE CORTICOSTEROID OR CATABOLIC KILLER? , 2019, European cells & materials.

[14]  M. Easley,et al.  Analysis of “old” proteins unmasks dynamic gradient of cartilage turnover in human limbs , 2019, Science Advances.

[15]  P. Conaghan,et al.  Update on novel pharmacological therapies for osteoarthritis , 2019, Therapeutic advances in musculoskeletal disease.

[16]  A. Grodzinsky,et al.  Human cartilage-bone-synovium microphysiological system to study ptoa pathogenesis and treatment on earth and in space , 2019, Osteoarthritis and Cartilage.

[17]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[18]  David R. Liu,et al.  Green fluorescent proteins engineered for cartilage-targeted drug delivery: Insights for transport into highly charged avascular tissues. , 2018, Biomaterials.

[19]  E. Yi,et al.  Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis , 2018, Annals of the rheumatic diseases.

[20]  Hylton B Menz,et al.  Population prevalence and distribution of ankle pain and symptomatic radiographic ankle osteoarthritis in community dwelling older adults: A systematic review and cross-sectional study , 2018, PloS one.

[21]  C. Netzer,et al.  Novel Ex Vivo Human Osteochondral Explant Model of Knee and Spine Osteoarthritis Enables Assessment of Inflammatory and Drug Treatment Responses , 2018, International journal of molecular sciences.

[22]  G. Loots,et al.  SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  A. Grodzinsky,et al.  Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis. , 2017, European cells & materials.

[24]  A. Grodzinsky,et al.  Quantitative proteomics analysis of cartilage response to mechanical injury and cytokine treatment. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[25]  A. Grodzinsky,et al.  Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity , 2017, Arthritis Research & Therapy.

[26]  L. Bonassar,et al.  Post‐traumatic osteoarthritis of the ankle: A distinct clinical entity requiring new research approaches , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  Laurent Gatto,et al.  Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies. , 2016, Journal of proteome research.

[28]  V. Kraus,et al.  Elucidating the Molecular Composition of Cartilage by Proteomics. , 2016, Journal of proteome research.

[29]  P. Hammond,et al.  Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term. , 2015, Osteoarthritis and cartilage.

[30]  Gui-quan Cai,et al.  Autophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS/Akt/FOXO3 signaling. , 2015, Osteoarthritis and cartilage.

[31]  E. Charlier,et al.  Apolipoprotein-A1 as a Damage-Associated Molecular Patterns Protein in Osteoarthritis: Ex Vivo and In Vitro Pro-Inflammatory Properties , 2015, PloS one.

[32]  W. Lems,et al.  Proteasome inhibitors as experimental therapeutics of autoimmune diseases , 2015, Arthritis Research & Therapy.

[33]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[34]  B Schoeberl,et al.  Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis. , 2014, Osteoarthritis and cartilage.

[35]  A. Grodzinsky,et al.  Novel Cartilage Oligomeric Matrix Protein (COMP) Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases Using Affinity Chromatography and Mass Spectrometry* , 2014, The Journal of Biological Chemistry.

[36]  Riccardo Gottardi,et al.  Stem Cell-Based Microphysiological Osteochondral System to Model Tissue Response to Interleukin-1β , 2014, Molecular pharmaceutics.

[37]  Shu-guang Gao,et al.  Association of osteopontin with osteoarthritis , 2014, Rheumatology International.

[38]  C. Frank,et al.  Dexamethasone inhibits inflammation and cartilage damage in a new model of post‐traumatic osteoarthritis , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[39]  B. Fadeel,et al.  Dexamethasone differentially regulates Bcl-2 family proteins in human proliferative chondrocytes: role of pro-apoptotic Bid. , 2014, Toxicology letters.

[40]  Rocky S Tuan,et al.  Three-dimensional osteochondral microtissue to model pathogenesis of osteoarthritis , 2013, Stem Cell Research & Therapy.

[41]  Alan J. Grodzinsky,et al.  Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, TNF-α and IL-6, but accentuates degradation above a strain threshold , 2013 .

[42]  Steven D Chang,et al.  Acknowledgement of Reviewers 2012 , 2013, Dysphagia (New York. Print).

[43]  R. Weinstein.  Glucocorticoid-induced osteoporosis and osteonecrosis. , 2012, Endocrinology and metabolism clinics of North America.

[44]  A. Grodzinsky,et al.  Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines , 2011, Arthritis research & therapy.

[45]  Hong-Liang Zhang,et al.  Cross-Talk between Apolipoprotein E and Cytokines , 2011, Mediators of inflammation.

[46]  L. Cui,et al.  [Effects of different doses of dexamethasone on bone qualities in rats]. , 2010, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi.

[47]  Xiao-Yu Song,et al.  Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. , 2009, Arthritis and rheumatism.

[48]  S. Seong,et al.  Apolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxin , 2009, Immunology.

[49]  L. Sorell,et al.  Circulating 20S Proteasome Levels in Patients with Mixed Connective Tissue Disease and Systemic Lupus Erythematosus , 2008, Clinical and Vaccine Immunology.

[50]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[51]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Simpson,et al.  Chondrocyte death associated with human femoral osteochondral harvest as performed for mosaicplasty. , 2005, The Journal of bone and joint surgery. American volume.

[53]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[54]  J. Saklatvala.  Glucocorticoids: do we know how they work? , 2002, Arthritis Research & Therapy.

[55]  P. Patwari,et al.  Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. , 2000, Archives of biochemistry and biophysics.

[56]  S B Rosalki,et al.  BIOCHEMICAL MARKERS OF BONE TURNOVER , 1998, International journal of clinical practice.

[57]  H. Inoue,et al.  Expression of osteonectin in articular cartilage of osteoarthritic knees. , 1997, Acta medica Okayama.

[58]  M. Noshiro,et al.  Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. , 1996, Arthritis and rheumatism.

[59]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.